These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31038003)

  • 21. Phenotypic variability in a portuguese family with x-linked creatine transport deficiency.
    Garcia P; Rodrigues F; Valongo C; Salomons GS; Diogo L
    Pediatr Neurol; 2012 Jan; 46(1):39-41. PubMed ID: 22196490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creatine Transporter Deficiency Presenting as Autism Spectrum Disorder.
    Yıldız Y; Göçmen R; Yaramış A; Coşkun T; Haliloğlu G
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33093139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
    Cacciante F; Gennaro M; Sagona G; Mazziotti R; Lupori L; Cerri E; Putignano E; Butt M; Do MT; McKew JC; Alessandrì MG; Battini R; Cioni G; Pizzorusso T; Baroncelli L
    Sci Rep; 2020 Oct; 10(1):18361. PubMed ID: 33110151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimated carrier frequency of creatine transporter deficiency in females in the general population using functional characterization of novel missense variants in the SLC6A8 gene.
    DesRoches CL; Patel J; Wang P; Minassian B; Salomons GS; Marshall CR; Mercimek-Mahmutoglu S
    Gene; 2015 Jul; 565(2):187-91. PubMed ID: 25861866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency.
    Kurosawa Y; Degrauw TJ; Lindquist DM; Blanco VM; Pyne-Geithman GJ; Daikoku T; Chambers JB; Benoit SC; Clark JF
    J Clin Invest; 2012 Aug; 122(8):2837-46. PubMed ID: 22751104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creatine transport and pathological changes in creatine transporter deficient mice.
    Wawro AM; Gajera CR; Baker SA; Nirschl JJ; Vogel H; Montine TJ
    J Inherit Metab Dis; 2021 Jul; 44(4):939-948. PubMed ID: 33389772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of the Molecular Defects Associated with Pathogenic Variants of the
    Salazar MD; Zelt NB; Saldivar R; Kuntz CP; Chen S; Penn WD; Bonneau R; Koehler Leman J; Schlebach JP
    Biochemistry; 2020 Apr; 59(13):1367-1377. PubMed ID: 32207963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional assessment of creatine transporter in control and X-linked SLC6A8-deficient fibroblasts.
    Joncquel-Chevalier Curt M; Bout MA; Fontaine M; Kim I; Huet G; Bekri S; Morin G; Moortgat S; Moerman A; Cuisset JM; Cheillan D; Vamecq J
    Mol Genet Metab; 2018 Apr; 123(4):463-471. PubMed ID: 29478817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable White Matter Atrophy and Intellectual Development in a Family With X-linked Creatine Transporter Deficiency Despite Genotypic Homogeneity.
    Heussinger N; Saake M; Mennecke A; Dörr HG; Trollmann R
    Pediatr Neurol; 2017 Feb; 67():45-52. PubMed ID: 28065824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency.
    Mabondzo A; Harati R; Broca-Brisson L; Guyot AC; Costa N; Cacciante F; Putignano E; Baroncelli L; Skelton MR; Saab C; Martini E; Benech H; Joudinaud T; Gaillard JC; Armengaud J; Hamoudi R
    Front Mol Neurosci; 2023; 16():1118707. PubMed ID: 37063368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-linked creatine transporter deficiency results in prolonged QTc and increased sudden death risk in humans and disease model.
    Levin MD; Bianconi S; Smith A; Cawley NX; Do AD; Hammond D; Grafstein JF; Thurm A; Miller J; Perreault J; Noguchi A; Springer D; Kozel BA; Spurney CF; Wassif CA; Yu ZX; Schulze A; Porter FD; Hannah-Shmouni F
    Genet Med; 2021 Oct; 23(10):1864-1872. PubMed ID: 34050321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes.
    Comeaux MS; Wang J; Wang G; Kleppe S; Zhang VW; Schmitt ES; Craigen WJ; Renaud D; Sun Q; Wong LJ
    Mol Genet Metab; 2013 Jul; 109(3):260-8. PubMed ID: 23660394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Elucidation of Disease Mechanisms Based on Transport Function at Tissue Barriers and Challenges in Drug Development].
    Ito S
    Yakugaku Zasshi; 2019; 139(4):497-503. PubMed ID: 30930376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Nervous System-Specific Model of Creatine Transporter Deficiency Recapitulates the Cognitive Endophenotype of the Disease: a Longitudinal Study.
    Molinaro A; Alessandrì MG; Putignano E; Leuzzi V; Cioni G; Baroncelli L; Pizzorusso T
    Sci Rep; 2019 Jan; 9(1):62. PubMed ID: 30635645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism.
    Duran-Trio L; Fernandes-Pires G; Simicic D; Grosse J; Roux-Petronelli C; Bruce SJ; Binz PA; Sandi C; Cudalbu C; Braissant O
    Sci Rep; 2021 Jan; 11(1):1636. PubMed ID: 33452333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
    Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging.
    Baroncelli L; Molinaro A; Cacciante F; Alessandrì MG; Napoli D; Putignano E; Tola J; Leuzzi V; Cioni G; Pizzorusso T
    Hum Mol Genet; 2016 Oct; 25(19):4186-4200. PubMed ID: 27466184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of the creatine transporter gene in neonatal, but not adult, mice leads to cognitive deficits.
    Udobi KC; Delcimmuto N; Kokenge AN; Abdulla ZI; Perna MK; Skelton MR
    J Inherit Metab Dis; 2019 Sep; 42(5):966-974. PubMed ID: 31209903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency.
    Adriano E; Gulino M; Arkel M; Salis A; Damonte G; Liessi N; Millo E; Garbati P; Balestrino M
    Neurosci Lett; 2018 Feb; 665():217-223. PubMed ID: 29229397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders.
    Stockler-Ipsiroglu S; van Karnebeek CD
    Semin Neurol; 2014 Jul; 34(3):350-6. PubMed ID: 25192512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.